125 related articles for article (PubMed ID: 9136964)
1. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets.
Savi P; Artçanuthurry V; Bornia J; Grelac F; Maclouf J; Levy-Toledano S; Herbert JM
Br J Haematol; 1997 Apr; 97(1):185-91. PubMed ID: 9136964
[TBL] [Abstract][Full Text] [Related]
2. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
3. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
4. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.
Gachet C; Cattaneo M; Ohlmann P; Hechler B; Lecchi A; Chevalier J; Cassel D; Mannucci PM; Cazenave JP
Br J Haematol; 1995 Oct; 91(2):434-44. PubMed ID: 8547091
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the existence of two different ADP-binding sites on rat platelets.
Savi P; Laplace MC; Herbert JM
Thromb Res; 1994 Oct; 76(2):157-69. PubMed ID: 7863466
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
7. Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel.
Savi P; Bornia J; Salel V; Delfaud M; Herbert JM
Br J Haematol; 1997 Sep; 98(4):880-6. PubMed ID: 9326183
[TBL] [Abstract][Full Text] [Related]
8. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
9. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
10. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
[TBL] [Abstract][Full Text] [Related]
11. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation.
Humbert M; Nurden P; Bihour C; Pasquet JM; Winckler J; Heilmann E; Savi P; Herbert JM; Kunicki TJ; Nurden AT
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1532-43. PubMed ID: 8977459
[TBL] [Abstract][Full Text] [Related]
14. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
15. ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel.
Gachet C; Savi P; Ohlmann P; Maffrand JP; Jakobs KH; Cazenave JP
Thromb Haemost; 1992 Jul; 68(1):79-83. PubMed ID: 1514178
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
[TBL] [Abstract][Full Text] [Related]
18. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
19. The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine.
Lalé A; Herbert JM; Savi P
Thromb Haemost; 2003 Nov; 90(5):839-43. PubMed ID: 14597979
[TBL] [Abstract][Full Text] [Related]
20. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel.
Geiger J; Brich J; Hönig-Liedl P; Eigenthaler M; Schanzenbächer P; Herbert JM; Walter U
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):2007-11. PubMed ID: 10446085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]